Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (251)

« Back to Publications

Dynamics of the blood plasma proteome during hyperacute HIV-1 infection.

Nazziwa J. et al, (2024), Nat Commun, 15

Type 1 Human Immunodeficiency Virus (HIV-1) Incidence, Adherence, and Drug Resistance in Individuals Taking Daily Emtricitabine/Tenofovir Disoproxil Fumarate for HIV-1 Pre-exposure Prophylaxis: Pooled Analysis From 72 Global Studies.

Landovitz RJ. et al, (2024), Clin Infect Dis, 79, 1197 - 1207

Profiling IgG and IgA antibody responses during vaccination and infection in a high-risk gonorrhoea population.

Stejskal L. et al, (2024), Nat Commun, 15

HLA-A*23 Is Associated With Lower Odds of Acute Retroviral Syndrome in Human Immunodeficiency Virus Type 1 Infection: A Multicenter Sub-Saharan African Study.

Lindquist L. et al, (2024), Open Forum Infect Dis, 11

Impact of coronavirus disease 2019-related clinic closures on HIV incidence in young adult MSM and transgender women in Kenya.

Wahome E. et al, (2024), AIDS, 38, 407 - 413

Temporal trends and transmission dynamics of pre-treatment HIV-1 drug resistance within and between risk groups in Kenya, 1986-2020.

Nduva GM. et al, (2024), J Antimicrob Chemother, 79, 287 - 296

The Effect of the Shikamana Peer-and-Provider Intervention on Depressive Symptoms, Alcohol Use, and Other Drug Use Among Gay, Bisexual, and Other Men Who Have Sex with Men in Kenya.

Graff NR. et al, (2023), AIDS Behav, 27, 3053 - 3063

Modeling the impact of different PrEP targeting strategies combined with a clinic-based HIV-1 nucleic acid testing intervention in Kenya.

Hamilton DT. et al, (2023), Epidemics, 44

Transgender women in Kenya experience greater stigma, depressive symptoms, alcohol and drug use and risky sexual practices than cis-gendered men who have sex with men.

Mehta SD. et al, (2023), BMC Public Health, 23

Immunogenicity and safety of fractional doses of 17D-213 yellow fever vaccine in HIV-infected people in Kenya (YEFE): a randomised, double-blind, non-inferiority substudy of a phase 4 trial.

Kimathi D. et al, (2023), Lancet Infect Dis, 23, 974 - 982

There are three major Neisseria gonorrhoeae β-lactamase plasmid variants which are associated with specific lineages and carry distinct TEM alleles.

Elsener TA. et al, (2023), Microb Genom, 9

Antigen pressure from two founder viruses induces multiple insertions at a single antibody position to generate broadly neutralizing HIV antibodies.

Joyce C. et al, (2023), PLoS Pathog, 19

URCHOICE: Preferences for Pre-Exposure Prophylaxis (PrEP) Options for HIV Prevention Among Kenyan men who have sex with men and Transgender Women in Nairobi, Kisumu and the Coast.

Bailey RC. et al, (2023), AIDS Behav, 27, 25 - 36

Exposure to common infections may shape basal immunity and potentially HIV-1 acquisition amongst a high-risk population in Coastal Kenya.

Fwambah L. et al, (2023), Front Immunol, 14

Developing a diversity, equity and inclusion compass to guide scientific capacity strengthening efforts in Africa.

Kasprowicz VO. et al, (2023), PLOS Glob Public Health, 3

Load More

1
2
3
4
5
6
7
...
»